Kamada Ltd. (KMDA)
Automate Your Wheel Strategy on KMDA
With Tiblio's Option Bot, you can configure your own wheel strategy including KMDA - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol KMDA
- Rev/Share 2.9416
- Book/Share 4.7696
- PB 1.4446
- Debt/Equity 0.0426
- CurrentRatio 3.7326
- ROIC 0.0669
- MktCap 396209450.0
- FreeCF/Share 0.673
- PFCF 10.8215
- PE 25.9173
- Debt/Assets 0.0297
- DivYield 0.029
- ROE 0.0573
- Rating A-
- Score 4
- Recommendation Buy
- P/E Score 2
- DCF Score 4
- P/B Score 3
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | KMDA | The Benchmark Company | -- | Buy | -- | $15 | March 21, 2025 |
News
KMDA vs. CSLLY: Which Stock Should Value Investors Buy Now?
Published: May 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Kamada (KMDA) or CSL Limited Sponsored ADR (CSLLY). But which of these two stocks presents investors with the better value opportunity right now?
Read More
Kamada Ltd. (KMDA) Q1 2025 Earnings Call Transcript
Published: May 14, 2025 by: Seeking Alpha
Sentiment: Neutral
Start Time: 08:30 January 1, 0000 8:53 AM ET Kamada Ltd. (NASDAQ:KMDA ) Q1 2025 Earnings Conference Call May 14, 2025, 08:30 AM ET Company Participants Amir London - CEO Chaime Orlev - CFO Brian Ritchie - LifeSci Advisors Conference Call Participants Annabel Samimy - Stifel James Sidoti - Sidoti & Company Operator Greetings, and welcome to the Kamada First Quarter 2025 Earnings Conference Call.
Read More
Kamada (KMDA) Q1 Earnings Match Estimates
Published: May 14, 2025 by: Zacks Investment Research
Sentiment: Neutral
Kamada (KMDA) came out with quarterly earnings of $0.07 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.04 per share a year ago.
Read More
Kamada (KMDA) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates
Published: May 09, 2025 by: Zacks Investment Research
Sentiment: Neutral
Besides Wall Street's top -and-bottom-line estimates for Kamada (KMDA), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2025.
Read More
Kamada to Announce Fourth Quarter and Fiscal Year 2024 Financial Results on March 5, 2025
Published: February 26, 2025 by: GlobeNewsWire
Sentiment: Neutral
REHOVOT, Israel, and HOBOKEN, N.J., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd.
Read More
About Kamada Ltd. (KMDA)
- IPO Date 2013-05-31
- Website https://www.kamada.com
- Industry Drug Manufacturers - Specialty & Generic
- CEO Mr. Amir London
- Employees 420